COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …
Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study
Background Individuals admitted to hospital for COVID-19 might have persisting symptoms
(so-called long COVID) and delayed complications after discharge. However, little is known …
(so-called long COVID) and delayed complications after discharge. However, little is known …
Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on …
E Cenko, L Badimon, R Bugiardini… - Cardiovascular …, 2021 - academic.oup.com
The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …
Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar
G Giustino, SP Pinney, A Lala, VY Reddy… - Journal of the American …, 2020 - jacc.org
The cardiovascular system is affected broadly by severe acute respiratory syndrome
coronavirus 2 infection. Both direct viral infection and indirect injury resulting from …
coronavirus 2 infection. Both direct viral infection and indirect injury resulting from …
Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research
B Bikdeli, MV Madhavan, A Gupta… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The …
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The …
REHABILITATION OF COVID-19 PATIENTS WITH ACUTE LOWER EXTREMITY ISCHAEMIA AND AMPUTATION.
L Brugliera, A Spina, P Castellazzi… - Journal of …, 2020 - search.ebscohost.com
Objective: To evaluate the clinical characteristics and rehabilitation management of patients
who undergo amputation for COVID-19-associated coagulopathy. Methods: Clinical and …
who undergo amputation for COVID-19-associated coagulopathy. Methods: Clinical and …
Coronavirus disease 2019–associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management
L Ortega‐Paz, D Capodanno… - Journal of the …, 2021 - Am Heart Assoc
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …
Current overview on hypercoagulability in COVID-19
N Singhania, S Bansal, DP Nimmatoori, AA Ejaz… - American Journal of …, 2020 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies …
Arterial thrombosis in coronavirus disease 2019 patients: a rapid systematic review
I Cheruiyot, V Kipkorir, B Ngure, M Misiani… - Annals of vascular …, 2021 - Elsevier
Background Emerging evidence suggests that severe form of coronavirus disease 2019
(COVID-19) is mediated, in part, by a hypercoagulable state characterized by micro-and …
(COVID-19) is mediated, in part, by a hypercoagulable state characterized by micro-and …